Cargando…
Challenges in long-term control of hypercalcaemia with denosumab after haematopoietic stem cell transplantation for TNFRSF11A osteoclast-poor autosomal recessive osteopetrosis
Autosomal recessive osteopetrosis (ARO) is rare, involving increased bone density due to defective osteoclast differentiation or function, with several genetic subtypes. CASE: This child with compound heterozygous novel loss-of-function TNFRSF11A pathogenic variants causing osteoclast-poor ARO under...
Autores principales: | Taylor-Miller, Tashunka, Sivaprakasam, Ponni, Smithson, Sarah F., Steward, Colin G., Burren, Christine P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750151/ https://www.ncbi.nlm.nih.gov/pubmed/33364264 http://dx.doi.org/10.1016/j.bonr.2020.100738 |
Ejemplares similares
-
Autosomal recessive osteopetrosis: mechanisms and treatments
por: Penna, Sara, et al.
Publicado: (2021) -
Intermediate Autosomal Recessive Osteopetrosis With an Unusual Absence of Fractures
por: Ishaque, Ali, et al.
Publicado: (2022) -
Prenatal diagnosis of autosomal recessive osteopetrosis: a case report
por: Mistri, Mehul, et al.
Publicado: (2014) -
Bone Turnover Marker for the Evaluation of Skeletal Remodelling in Autosomal Recessive Osteopetrosis after Haematopoietic Stem Cell Transplantation: A Case Report
por: Horváth, Máté, et al.
Publicado: (2023) -
Treatment of immobilization-related hypercalcaemia with denosumab
por: Malberti, Fabio
Publicado: (2012)